ANO1 and prostate carcinoma: Several recent studies have shown that ANO1 (TMEM16A) is overexpressed in many cancer types such as breast cancer, head and neck squamous cell carcinoma (HNSCC), prostate cancer, colorectal cancer, and glioma (Table 2) [133].